leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   807 Trials   807 Trials   14372 News 


«12...224225226227228229230231232233234...235236»
  • ||||||||||  Cyramza (ramucirumab) / Eli Lilly, icrucumab (IMC-18F1) / Eli Lilly
    Enrollment closed, Combination therapy, Metastases:  A Study of Ramucirumab or Icrucumab in Colorectal Cancer (clinicaltrials.gov) -  Mar 10, 2013   
    P2,  N=156, Active, not recruiting, 
    N=224 --> 0 Recruiting --> Active, not recruiting
  • ||||||||||  saridegib oral (IPI 926 oral) / Infinity Pharma
    Enrollment closed, Metastases:  FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma (clinicaltrials.gov) -  Mar 3, 2013   
    P1,  N=21, Active, not recruiting, 
    N=42 --> 63 Recruiting --> Active, not recruiting
  • ||||||||||  5-fluorouracil / Generic mfg., metformin / Generic mfg., leucovorin calcium / Generic mfg.
    Trial initiation date, Metastases:  Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer (clinicaltrials.gov) -  Feb 17, 2013   
    P2,  N=43, Recruiting, 
    Recruiting --> Active, not recruiting Initiation date: Sep 2012 --> Feb 2013
  • ||||||||||  5-fluorouracil / Generic mfg., metformin / Generic mfg., leucovorin calcium / Generic mfg.
    Enrollment open, Metastases:  Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer (clinicaltrials.gov) -  Feb 17, 2013   
    P2,  N=43, Recruiting, 
    N=20 --> 13 Not yet recruiting --> Recruiting
  • ||||||||||  5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg.
    Trial termination:  Neo-Adjuvant FOLFOX for Rectal Carcinoma (clinicaltrials.gov) -  Feb 12, 2013   
    P2,  N=2, Terminated, 
    Active, not recruiting --> Recruiting Recruiting --> Terminated; terminated for lack of enrollment
  • ||||||||||  5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg.
    Enrollment change:  Neo-Adjuvant FOLFOX for Rectal Carcinoma (clinicaltrials.gov) -  Feb 12, 2013   
    P2,  N=2, Terminated, 
    Recruiting --> Terminated; terminated for lack of enrollment N=22 --> 2
  • ||||||||||  5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
    Enrollment closed, Metastases:  Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC (clinicaltrials.gov) -  Feb 9, 2013   
    P3,  N=390, Active, not recruiting, 
    N=50 --> 16 Recruiting --> Active, not recruiting
  • ||||||||||  Zaltrap (ziv-aflibercept IV) / Sanofi
    Enrollment open, Metastases:  FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer (clinicaltrials.gov) -  Feb 6, 2013   
    P2,  N=64, Recruiting, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting